vimarsana.com

Michael Yu Dechao News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

Beijing wants cheaper, better drugs. That’s pressuring drug makers to innovate as generics become more competitive.

Hong kongSan franciscoUnited statesBritish columbiaNew yorkStephen peepelsLin xiaoweiAscletis pharmaMichael yu dechaoMorgan huangCharles li xiaojiaHogan lovellsHuang guobinInnovent biologicsZai labJp morgan chase co

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China s cancer treatment market?

Research and development costs run up against a ceiling over treatment prices, a very pertinent concern in China, where the government is anxious to keep health care affordable, in keeping with its socialist principle of governance

Hong kongLuo jiarongBristol myer opdivoInnovent biologicsBristol myers squibbMichael yu dechaoWu yuJunshi biosciencesEli lillyMerck keytrudaShanghai pharmaceuticals holdingUs federal drug administrationShanghai junshi biosciencesCommunist party ledMyers squibbUnited states based

vimarsana © 2020. All Rights Reserved.